Rosetta flexpepdock to predict peptide-mhc binding: an approach for non-canonical amino acids

HIGHLIGHTS

• who: Nathaniel Bloodworth and colleagues from the Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, for Drug Discovery, Leipzig University, Leipzig, Germany have published the research: Rosetta FlexPepDock to predict peptide-MHC binding: An approach for non-canonical amino acids, in the Journal: PLOS ONE of April/29,/2022
• what: The authors demonstrate the protocol`s ability to accurately recapitulate HLA-A 02:01 bound phosphopeptide backbone structures and relative binding affinity changes the theoretical structure of the lymphocytic choriomeningitis derived glycosylated peptide GP392 bound to MHC-I H-2Db and isolevuglandin . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.